CHEP GUIDELINES

No abstract text is available yet for this article.

The Canadian Hypertension Education Program (CHEP), Canadian Hypertension Society, Blood Pressure Canada, Canadian Diabetes Association, College of Family Physicians of Canada, Canadian Pharmacists Association, Heart and Stroke Foundation of Canada, and the Canadian Council of Cardiovascular Nurses issued a recent call for all health care professionals in Canada to double their efforts to assist patients with diabetes in maintaining target blood pressures (Campbell et al., 2009b). Blood pressure (B/P) in diabetic individuals should be less than 130 mmHg systolic and less than 80 mmHg diastolic (CHEP 2009)...

For the last 10 years, the update of guidelines for the treatment of hypertension in Canada is part of an annual process. This national strategy called the Canadian Hypertension Education Program (CHEP) has an organizational structure which allows not only to revise guidelines using an evidence-based scientific process but also to facilitate the implementation and the dissemination of the recommendations to the various healthcare professionals (doctors, pharmacists, nurses, etc.). As part of this process, the CHEP is also measuring different outcomes which could estimate the impact of its interventions...

No abstract text is available yet for this article.

BACKGROUND: In 1999, the Canadian Hypertension Education Program (CHEP) was launched to develop and implement evidence-based hypertension guidelines. OBJECTIVES: To determine temporal trends in antihypertensive drug prescribing and physician visits for hypertension in Canada, and correlate these trends with CHEP recommendations. METHODS: Longitudinal drug data (Intercontinental Medical Statistics [IMS] CompuScript database; IMS Health Canada) were used to examine prescriptions over an 11-year period (1996 to 2006) for five major cardiovascular drug classes...

The Canadian Hypertension Education Program (CHEP) is a unique Canadian initiative to improve awareness, treatment and control of hypertension through the education of health care professionals. It is the culmination of an over 30-year effort in the development of hypertension management recommendations in Canada. Important transitions in this evolution included adoption of a consensus approach, rigorous evidence grading, enhanced dissemination strategies, recommendation consolidation, sophisticated adjudication procedures, an annual process and the 'branding' of the effort as a distinct entity...

PURPOSE: The Canadian Hypertension Education Program (CHEP) was initiated in 1999 to improve hypertension management in Canada. The objective of the present study was to compare antihypertensive pharmacotherapy in Canada before and after the CHEP. METHODS: Data were obtained from the longitudinal National Population Health Surveys, which consisted of five cycles at two-year intervals from 1994 to 2002. Recent hypertensive respondents 20 years of age and older were identified the first time hypertension was reported or treated, and were included in a study population of 1453 newly diagnosed hypertensive patients...

BACKGROUND: It is uncertain whether patients with renal vascular disease will have renal or mortality benefit from re-establishing renal blood flow with renal revascularization procedures. The RAVE study will compare renal revascularization to medical management for people with atherosclerotic renal vascular disease (ARVD) and the indication for revascularization. Patients will be assessed for the standard nephrology research outcomes of progression to doubling of creatinine, need for dialysis, and death, as well as other cardiovascular outcomes...

The diffusion of research evidence or practice guidelines does not, by itself, lead to changes in practice behaviour or patient outcomes. The Canadian Hypertension Education Program (CHEP) was specifically structured to have an explicit process to improve the ability of primary care professionals to use CHEP recommendations. The key features of this process are reviewed in the present report. The responsibility for implementation of recommendations is divided between the executive committee of CHEP and the Implementation Task Force (ITF)...

The present report is an update on the contribution of the Canadian Hypertension Education Program's (CHEP) Outcomes Research Task Force to the surveillance and monitoring efforts surrounding hypertension and hypertension-related conditions in Canada. Components of the program include advocating national physical measures surveys of blood pressure; analysis of national cross-sectional and longitudinal population-based health surveys that assess hypertension diagnosis and treatment; assessment of national and regional pharmacotherapy patterns using existing commercial databases; assessment of national and regional trends in hypertensive complications (stroke, myocardial infarction and congestive heart failure); development of a national system based on provincial administrative data to assess the incidence, prevalence and management of diagnosed hypertension; and assessing some aspects of CHEP implementation...

BACKGROUND: Hypertension is the most important modifiable cause of stroke. The Canadian Hypertension Educational Program, representing Canada's experts in the field of hypertension, publishes annual evidence-based recommendations on the diagnosis and treatment of hypertension. METHODS: We present the 2005 Canadian Hypertension Educational Program guidelines regarding the management of hypertension in patients with stroke. RESULTS: The diagnosis of hypertension should be expedited and can be made as early as the second visit in patients with stroke...

OBJECTIVE: Poor control of hypertension is a world-wide health issue. In 1999, the Canadian Hypertension Education Program (CHEP) was launched to annually develop and implement evidence-based hypertension guidelines in an effort to improve hypertension control rates. This study was designed to examine temporal trends in antihypertensive drug prescribing and to explore whether drug prescriptions changed after initiation of the new CHEP guideline process. DESIGN AND METHODS: We used longitudinal Canadian dispensing data (from the IMS CompuScript database; IMS Health, Pointe-Claire, Quebec) to examine antihypertensive prescriptions in the 3 years prior to and the 3 years following introduction of the new CHEP process...